Recent Posts
- Amira Therapeutics’ Lead Compound AMI463 Demonstrates 60% Tumor Reduction in Preclinical Oral Study
- Amira Therapeutics Receives Orphan Drug Designation for AMI463 in Soft Tissue Sarcoma in the United States
- Cell biology of protein–lipid conjugation
- Targeting the Hedgehog Pathway in Rhabdomyosarcoma
- RCAN1-mediated calcineurin inhibition as a target for cancer therapy
Recent Comments
No comments to show.